Atlas Trials

Renal Allograft Recipients

4 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Renal Allograft Recipients

RecordFirmDate
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications (NCT04877288)Bristol-Myers Squibb2021-07-21
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients (NCT00895583)Pfizer2009-06-01
Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients (NCT00470665)Wyeth is now a wholly owned subsidiary of Pfizer2002-08-01

Track Renal Allograft Recipients automatically

Every clearance here is in the API, with alerts when new ones post.